Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase 2 Elara Study

Autor: Thieblemont, Catherine, Dickinson, Michael, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A., Ho, P Joy, Pérez-Simón, José Antonio, Chen, Andy I., Nastoupil, Loretta J., von Tresckow, Bastian, María Ferreri, Andrés José, Teshima, Takanori, Patten, Piers EM, McGuirk, Joseph P., Petzer, Andreas, Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Bodoni, Chiara Lobetti, Masood, Aisha, Schuster, Stephen J., Fowler, Nathan H., Dreyling, Martin
Zdroj: Transplantation and Cellular Therapy; March 2022, Vol. 28 Issue: 3, Number 3 Supplement 1 pS63-S64, 2p
Databáze: Supplemental Index
Externí odkaz: